Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
64%
Heart Failure Hospitalization
49%
Confidence Interval
46%
Type 1 Diabetes Mellitus (T1DM)
42%
Patients with Heart Failure
37%
All-cause Mortality
32%
Acute Myocardial Infarction
30%
Hazard Ratio
30%
Myocardial Infarction
29%
Cardiovascular Mortality
27%
Type I Diabetes
26%
First Hospitalization
23%
Metformin
23%
Enalapril
21%
Cardiovascular Autonomic Neuropathy
21%
Without Diabetes
20%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
20%
Associated Risk
19%
Heart Failure Patients
18%
Sacubitril-valsartan
17%
Left Ventricular Function
16%
National Cohort Study
15%
Patients with Diabetes
15%
Comorbidity
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Heart Failure Trials
14%
Preserved Ejection Fraction
14%
Tracking Studies
14%
Two-dimensional Speckle Tracking
14%
Prognostic Value
14%
High Risk
13%
Cardiovascular Risk
13%
Odds Ratio
12%
Atrial Fibrillation
12%
Sulfonylurea
12%
Reduced Ejection Fraction
12%
Diabetes
11%
Diabetes Status
11%
Left Ventricular Strain
11%
AIMS™
10%
Composite Outcome
10%
Insulin
10%
Prognostic Importance
10%
Cardioverter-defibrillator Implantation
9%
Non-dipper
9%
Dipeptidyl peptidase-4 (DPP-4)
9%
Health-related Quality of Life
9%
Domiciliary Care
9%
PARADIGM-HF
9%
Ischemic Heart Failure
9%
Medicine and Dentistry
Heart Failure
56%
Cardiovascular System
43%
Diabetes
28%
Autonomic Neuropathy
25%
Diabetes Mellitus
23%
Acute Heart Infarction
18%
Glycon
18%
Patient with Type 1 Diabetes
18%
Insulin Dependent Diabetes Mellitus
18%
Myocardial Infarction
18%
Patient with Diabetes
15%
Ejection Fraction
14%
Coronary Artery
13%
Apoplexy
12%
All Cause Mortality
12%
Sulfonylurea
12%
Hazard Ratio
11%
Cardiovascular Disease
11%
Cardiovascular Risk
10%
Maturity Onset Diabetes of the Young
10%
Systolic Function
9%
Atrial Fibrillation
9%
Nursing Home
9%
Cohort Analysis
9%
Implantable Automatic Defibrillator
9%
Antihypertensive Therapy
9%
Placebo
9%
Blood Pressure
9%
Isotopes of Calcium
8%
Amino Terminal Sequence
7%
Brain Natriuretic Peptide
7%
Glucagon-Like Peptide-1 Agonist
7%
Quality of Life
6%
Multidetector Computed Tomography
6%
Heart Failure with Reduced Ejection Fraction
6%
Left Ventricular Systolic Dysfunction
5%
Adverse Outcome
5%
Heart Failure with Preserved Ejection Fraction
5%
Glycated Hemoglobin
5%
Enalapril
5%
Heart Ventricle Remodeling
5%
Complications of Diabetes Mellitus
5%
Artery
5%
Irbesartan
5%
Infection
5%
Patient with Type 2 Diabetes
5%
Prevalence
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Heart Infarction
35%
All Cause Mortality
33%
Metformin
23%
Diabetes Mellitus
17%
Acute Heart Infarction
16%
Valsartan/Sacubitril
16%
Brain Natriuretic Peptide
15%
Enalapril
14%
Non Insulin Dependent Diabetes Mellitus
14%
Atrial Fibrillation
14%
Cohort Study
14%
Adverse Outcome
13%
Sulfonylurea
12%
Cardiovascular Risk
9%
Dipeptidyl Peptidase IV Inhibitor
9%
Comorbidity
9%
Monotherapy
7%
Placebo
7%
Glucagon Like Peptide 1 Receptor Agonist
7%
Bacterial Endocarditis
6%
Aliskiren
5%
Heart Failure with Preserved Ejection Fraction
5%
Glycosylated Hemoglobin
5%
Irbesartan
5%
Infection
5%
Low Density Lipoprotein Cholesterol
5%
Chronic Obstructive Lung Disease
5%